|
Index of reports
> Cases with Death (204)
Below is the selection of side effect reports (a.k.a. adverse event reports) related to Cyclophosphamide where reactions include death. The selected reports were submitted to the FDA during the sample period of about a year. Reports 1 - 30 of 204 Next >>
Possible Cyclophosphamide side effects in male
Reported by a health professional (non-physician/pharmacist) from United States on 2012-08-24
Patient: male, weighing 103.1 kg (226.8 pounds)
Reactions: Plasmacytosis, Pneumonia, Mouth Haemorrhage, Pseudomonas Infection, Headache, Disease Progression, Death, Mucosal Inflammation, Pleural Effusion, Depressed Level of Consciousness, Abscess, Lethargy, RIB Fracture
Adverse event resulted in: death, hospitalization
Drug(s) suspected as cause:
Cisplatin
Indication: Multiple Myeloma
Cyclophosphamide
Indication: Multiple Myeloma
Dexamethasone
Indication: Multiple Myeloma
Doxorubicin Hydrochloride
Indication: Multiple Myeloma
Etoposide
Indication: Multiple Myeloma
Radiation Therapy NOS
Indication: Multiple Myeloma
Revlimid
Indication: Multiple Myeloma
Thalidomide
Indication: Multiple Myeloma
Velcade
Indication: Multiple Myeloma
Other drugs received by patient: Bendamustine Hydrochloride; Lenalidomide
Possible Cyclophosphamide side effects in male
Reported by a physician from United States on 2012-08-23
Patient: male
Reactions: Death, Chalazion
Adverse event resulted in: death
Drug(s) suspected as cause:
Cyclophosphamide
Indication: Multiple Myeloma
Dexamethasone
Indication: Multiple Myeloma
Lenalidomide
Indication: Multiple Myeloma
Velcade
Dosage: 2 mg, 1/week
Indication: Multiple Myeloma
Start date: 2009-08-13
End date: 2012-01-03
Other drugs received by patient: Bisphosphonates; Travoprost
Possible Cyclophosphamide side effects in
Reported by a health professional (non-physician/pharmacist) from Japan on 2012-08-20
Patient:
Reactions: Death, Lymphoma, Diffuse Large B-Cell Lymphoma
Adverse event resulted in: death
Drug(s) suspected as cause:
Cyclophosphamide
Indication: Diffuse Large B-Cell Lymphoma
Doxorubicin Hydrochloride
Indication: Diffuse Large B-Cell Lymphoma
Prednisolone
Indication: Diffuse Large B-Cell Lymphoma
Rituximab
Indication: Diffuse Large B-Cell Lymphoma
Vincristine
Indication: Diffuse Large B-Cell Lymphoma
Possible Cyclophosphamide side effects in 35 year old female
Reported by a physician from Philippines on 2012-08-16
Patient: 35 year old female, weighing 56.2 kg (123.6 pounds)
Reactions: Death
Adverse event resulted in: death
Drug(s) suspected as cause:
Cyclophosphamide
Dosage: form:vialtotal dose recieved:936 mg
Start date: 2010-11-04
Docetaxel
Dosage: form:vialtotal dose recieved:152 mg
Start date: 2010-09-02
Epirubicin
Dosage: form:vialtotal dose recieved:140 mg
Start date: 2010-11-04
Fluorouracil
Dosage: form:vial
Start date: 2010-11-04
Trastuzumab
Dosage: form:vialtotal dose recieved:336 mg
Start date: 2011-07-21
Trastuzumab
Dosage: form:vial
Possible Cyclophosphamide side effects in female
Reported by a physician from Philippines on 2012-08-13
Patient: female, weighing 56.2 kg (123.6 pounds)
Reactions: Death
Adverse event resulted in: death
Drug(s) suspected as cause:
Cyclophosphamide
Indication: Breast Cancer
Start date: 2010-11-04
Docetaxel
Indication: Breast Cancer
Start date: 2010-09-02
Epirubicin Hydrochloride
Indication: Breast Cancer
Start date: 2010-11-04
Fluorouracil
Indication: Breast Cancer
Start date: 2010-11-04
Herceptin
Indication: Breast Cancer
Start date: 2011-07-21
Herceptin
Possible Cyclophosphamide side effects in
Reported by a health professional (non-physician/pharmacist) from United Kingdom on 2012-08-13
Patient:
Reactions: Pulmonary Embolism, Multiple Myeloma, Peripheral Sensory Neuropathy, Constipation, Somnolence, Death, Complications of Transplant Surgery, Peripheral Motor Neuropathy, Thrombosis in Device, Blood Alkaline Phosphatase Increased, Pancytopenia, Multiple Fractures, Rash, Renal Failure, Osteonecrosis of JAW, Embolism, Hypothyroidism, Deep Vein Thrombosis, Infection
Adverse event resulted in: death
Drug(s) suspected as cause:
Cyclophosphamide
Indication: Multiple Myeloma
Dexamethasone
Dosage: 40 milligram
Administration route: Oral
Dexamethasone
Dosage: 20 milligram
Indication: Multiple Myeloma
Thalidomide
Dosage: or 4 weeks and increased every 4 weeks in 50-mg increments to a maximum of 200mg/day
Administration route: Oral
Indication: Multiple Myeloma
Other drugs received by patient: Melphalan Hydrochloride; Prednisolone; CLO; ZOL; Melphalan Hydrochloride; Biphosphonate; Vincristine; Doxorubicin Hydrochloride; Bortezomib
Possible Cyclophosphamide side effects in
Reported by a health professional (non-physician/pharmacist) from France on 2012-08-13
Patient:
Reactions: Death
Adverse event resulted in: death
Drug(s) suspected as cause:
Bleomycin
Dosage: days 1 and 5
Indication: Diffuse Large B-Cell Lymphoma
Cyclophosphamide
Indication: Diffuse Large B-Cell Lymphoma
Cyclophosphamide
Dosage: day 1
Doxorubicin HCL
Dosage: day 1
Indication: Diffuse Large B-Cell Lymphoma
Doxorubicin HCL
Dosage: day 1
Prednisone TAB
Dosage: days 1-5
Indication: Diffuse Large B-Cell Lymphoma
Rituximab
Dosage: day 1
Indication: Diffuse Large B-Cell Lymphoma
Vincristine
Dosage: day 1
Indication: Diffuse Large B-Cell Lymphoma
Vindesine
Dosage: days 1 and 5
Indication: Diffuse Large B-Cell Lymphoma
Other drugs received by patient: Fluorodeoxyglucose F 18
Possible Cyclophosphamide side effects in 35 year old female
Reported by a physician from Philippines on 2012-08-09
Patient: 35 year old female, weighing 56.2 kg (123.6 pounds)
Reactions: Death
Adverse event resulted in: death
Drug(s) suspected as cause:
Cyclophosphamide
Dosage: form:vialtotal dose recieved:936 mg
Start date: 2010-11-04
Docetaxel
Dosage: form:vialtotal dose recieved:152 mg
Start date: 2010-09-02
Epirubicin
Dosage: form:vialtotal dose recieved:140 mg
Start date: 2010-11-04
Fluorouracil
Dosage: form:vial
Start date: 2010-11-04
Trastuzumab
Dosage: form:vial
Trastuzumab
Dosage: form:vialtotal dose recieved:336 mg
Start date: 2011-07-21
Possible Cyclophosphamide side effects in
Reported by a physician from Israel on 2012-08-08
Patient:
Reactions: Death
Adverse event resulted in: death
Drug(s) suspected as cause:
Adriamycin PFS
Indication: Multiple Myeloma
Cisplatin
Indication: Multiple Myeloma
Cyclophosphamide
Indication: Multiple Myeloma
Dexamethasone
Indication: Multiple Myeloma
Etoposide
Indication: Multiple Myeloma
Thalidomide
Indication: Multiple Myeloma
Velcade
Indication: Multiple Myeloma
Possible Cyclophosphamide side effects in
Reported by a physician from China on 2012-08-07
Patient:
Reactions: Death
Adverse event resulted in: death
Drug(s) suspected as cause:
Cisplatin
Dosage: unk
Indication: Multiple Myeloma
Cyclophosphamide
Dosage: unk
Indication: Multiple Myeloma
Etoposide
Dosage: unk
Indication: Multiple Myeloma
Prednisone TAB
Dosage: unk
Indication: Multiple Myeloma
Velcade
Indication: Multiple Myeloma
Possible Cyclophosphamide side effects in
Reported by a physician from China on 2012-08-07
Patient:
Reactions: Death
Adverse event resulted in: death
Drug(s) suspected as cause:
Cisplatin
Indication: Multiple Myeloma
Cyclophosphamide
Indication: Multiple Myeloma
Etoposide
Indication: Multiple Myeloma
Prednisone TAB
Indication: Multiple Myeloma
Velcade
Indication: Multiple Myeloma
Possible Cyclophosphamide side effects in
Reported by a physician from China on 2012-08-07
Patient:
Reactions: Death
Adverse event resulted in: death
Drug(s) suspected as cause:
Cisplatin
Indication: Multiple Myeloma
Cyclophosphamide
Indication: Multiple Myeloma
Etoposide
Indication: Multiple Myeloma
Prednisone TAB
Indication: Multiple Myeloma
Velcade
Indication: Multiple Myeloma
Possible Cyclophosphamide side effects in male
Reported by a physician from United States on 2012-08-07
Patient: male, weighing 73.1 kg (160.8 pounds)
Reactions: Death
Adverse event resulted in: death, hospitalization
Drug(s) suspected as cause:
Cyclophosphamide
Dosage: 743 mg
End date: 2012-07-24
Doxorubicin Hydrochloride
Dosage: 79.2 mg
End date: 2012-07-24
Etoposide
Dosage: 396 mg
End date: 2012-07-24
Prednisone TAB
Dosage: 600 mg
End date: 2012-07-24
Other drugs received by patient: Vincristine Sulfate; Rituximab (Moab C2b8 Anti Cd20, Chimeric)
Possible Cyclophosphamide side effects in
Reported by a physician from China on 2012-08-07
Patient:
Reactions: Death
Adverse event resulted in: death
Drug(s) suspected as cause:
Cisplatin
Indication: Multiple Myeloma
Cyclophosphamide
Indication: Multiple Myeloma
Etoposide
Indication: Multiple Myeloma
Prednisone TAB
Indication: Multiple Myeloma
Velcade
Indication: Multiple Myeloma
Possible Cyclophosphamide side effects in
Reported by a physician from China on 2012-08-07
Patient:
Reactions: Death
Adverse event resulted in: death
Drug(s) suspected as cause:
Cisplatin
Indication: Multiple Myeloma
Cyclophosphamide
Indication: Multiple Myeloma
Etoposide
Indication: Multiple Myeloma
Prednisone TAB
Indication: Multiple Myeloma
Velcade
Indication: Multiple Myeloma
Possible Cyclophosphamide side effects in
Reported by a physician from Spain on 2012-08-06
Patient:
Reactions: Skin Toxicity, Sudden Death, Hepatic Failure, Encephalitis, Cytomegalovirus Colitis, Pneumonia Pneumococcal, Neurotoxicity, Death, Multi-Organ Failure, Metastasis, Cardiotoxicity, AIDS Dementia Complex, Pseudomonas Infection, Toxicity To Various Agents, Staphylococcal Infection, Pneumonia Herpes Viral, Neutropenia, Escherichia Infection, Infection
Adverse event resulted in: death
Drug(s) suspected as cause:
Cyclophosphamide
Dosage: given on day 1 of the 3 week cycle
Indication: Lymphoma AIDS Related
Doxorubicin HCL
Dosage: given on day 1 of the 3 week cycle
Indication: Lymphoma AIDS Related
Mabthera
Dosage: given on day 1 of every 3 week cycle (prior to chop)
Indication: Lymphoma AIDS Related
Prednisone TAB
Dosage: given for 5 days
Administration route: Oral
Indication: Lymphoma AIDS Related
Vincristine Sulfate
Dosage: given on day 1 of 3 week cycle.
Indication: Lymphoma AIDS Related
Other drugs received by patient: Hydrocortisone; Cytarabine; Methotrexate
Possible Cyclophosphamide side effects in female
Reported by a physician from Philippines on 2012-08-01
Patient: female, weighing 56.2 kg (123.6 pounds)
Reactions: Death
Adverse event resulted in: death
Drug(s) suspected as cause:
Cyclophosphamide
Indication: Breast Cancer
Start date: 2010-11-04
Docetaxel
Indication: Breast Cancer
Start date: 2010-09-02
Epirubicin Hydrochloride
Indication: Breast Cancer
Start date: 2010-11-04
Fluorouracil
Indication: Breast Cancer
Start date: 2010-11-04
Herceptin
Indication: Breast Cancer
Start date: 2011-07-21
Herceptin
Possible Cyclophosphamide side effects in 57 year old female
Reported by a pharmacist from Japan on 2012-07-27
Patient: 57 year old female
Reactions: Death
Adverse event resulted in: death
Drug(s) suspected as cause:
Cyclophosphamide
Dosage: 500 mg/m2, 1x/day
Indication: Breast Cancer
Start date: 2012-07-16
Epirubicin Hydrochloride
Dosage: 70 mg/m2, 1x/day
Indication: Breast Cancer
Start date: 2012-07-16
Fluorouracil
Dosage: 500 mg/m2, 1x/day
Indication: Breast Cancer
Start date: 2012-07-16
Possible Cyclophosphamide side effects in
Reported by a physician from China on 2012-07-25
Patient:
Reactions: Death
Adverse event resulted in: death
Drug(s) suspected as cause:
Cisplatin
Indication: Multiple Myeloma
Cyclophosphamide
Indication: Multiple Myeloma
Etoposide
Indication: Multiple Myeloma
Prednisone
Indication: Multiple Myeloma
Velcade
Indication: Multiple Myeloma
Possible Cyclophosphamide side effects in
Reported by a physician from China on 2012-07-25
Patient:
Reactions: Death
Adverse event resulted in: death
Drug(s) suspected as cause:
Cisplatin
Indication: Multiple Myeloma
Cyclophosphamide
Indication: Multiple Myeloma
Etoposide
Indication: Multiple Myeloma
Prednisone
Indication: Multiple Myeloma
Velcade
Indication: Multiple Myeloma
Possible Cyclophosphamide side effects in
Reported by a physician from China on 2012-07-25
Patient:
Reactions: Death
Adverse event resulted in: death
Drug(s) suspected as cause:
Cisplatin
Indication: Multiple Myeloma
Cyclophosphamide
Indication: Multiple Myeloma
Etoposide
Indication: Multiple Myeloma
Prednisone
Indication: Multiple Myeloma
Velcade
Indication: Multiple Myeloma
Possible Cyclophosphamide side effects in
Reported by a physician from China on 2012-07-25
Patient:
Reactions: Death
Adverse event resulted in: death
Drug(s) suspected as cause:
Cisplatin
Indication: Multiple Myeloma
Cyclophosphamide
Indication: Multiple Myeloma
Etoposide
Indication: Multiple Myeloma
Prednisone
Indication: Multiple Myeloma
Velcade
Indication: Multiple Myeloma
Possible Cyclophosphamide side effects in
Reported by a physician from China on 2012-07-25
Patient:
Reactions: Death
Adverse event resulted in: death
Drug(s) suspected as cause:
Cisplatin
Indication: Multiple Myeloma
Cyclophosphamide
Indication: Multiple Myeloma
Etoposide
Indication: Multiple Myeloma
Prednisone
Indication: Multiple Myeloma
Velcade
Indication: Multiple Myeloma
Possible Cyclophosphamide side effects in 53 year old male
Reported by a physician from United States on 2012-07-23
Patient: 53 year old male, weighing 61.6 kg (135.5 pounds)
Reactions: Death, Optic Nerve Disorder, Neuropathy Peripheral, Palmar-Plantar Erythrodysaesthesia Syndrome, Blindness, Progressive Multifocal Leukoencephalopathy, Peripheral Motor Neuropathy
Adverse event resulted in: death, hospitalization
Drug(s) suspected as cause:
Cyclophosphamide
Dosage: cycle 1
Indication: Lymphoma AIDS Related
Start date: 2008-04-08
End date: 2008-04-08
Cyclophosphamide
Dosage: cycle 6-1222mg in total
Start date: 2008-09-04
End date: 2008-09-04
Doxorubicin Hydrochloride
Dosage: on day 1
Indication: Lymphoma AIDS Related
Start date: 2008-04-08
End date: 2008-04-08
Doxorubicin Hydrochloride
Dosage: 6th cycle-49 mg in total
Start date: 2008-09-04
End date: 2008-09-04
Prednisone
Dosage: cycle 6- 500mg total
Administration route: Oral
Start date: 2008-09-04
End date: 2008-09-08
Prednisone
Dosage: days 1-5
Administration route: Oral
Indication: Lymphoma AIDS Related
Start date: 2008-04-08
End date: 2008-04-12
Rituximab
Dosage: cycle 6 - 611mg in total
Start date: 2008-09-04
End date: 2008-09-04
Rituximab
Dosage: cycle 1
Indication: Lymphoma AIDS Related
Start date: 2008-04-08
End date: 2008-04-08
Vincristine
Dosage: not more than 2 mg
Start date: 2008-04-08
End date: 2008-04-08
Vincristine
Dosage: cycle 6-2mg in total
Indication: Lymphoma AIDS Related
Start date: 2008-09-04
End date: 2008-09-04
Other drugs received by patient: Pegfilgrastim; Neupogen; Neupogen; Unknown Medication
Possible Cyclophosphamide side effects in
Reported by a physician from France on 2012-07-18
Patient:
Reactions: Death, Lung Infection, Myocardial Infarction
Adverse event resulted in: death, life threatening event, hospitalization
Drug(s) suspected as cause:
Cyclophosphamide
Dosage: 75 mg/m2, unk
Indication: Multiple Myeloma
Start date: 2011-11-04
End date: 2012-02-07
Dexamethasone
Dosage: 20 mg, unk
Administration route: Oral
Indication: Multiple Myeloma
Start date: 2011-11-04
End date: 2012-02-07
Velcade
Dosage: 2.4 mg, unk
Indication: Multiple Myeloma
End date: 2012-02-07
Other drugs received by patient: Bisoprolol Fumarate; Clopidogrel; Ezetimibe; Perindopril Erbumine; Lercanidipine; Plavix; Acetaminophen; Codeine Phosphate and Acetaminophen
Possible Cyclophosphamide side effects in
Reported by a health professional (non-physician/pharmacist) from Netherlands on 2012-07-16
Patient:
Reactions: Graft Versus Host Disease, Pulmonary Embolism, Toxicity To Various Agents, Polyneuropathy, Disease Progression, Death, Embolism Venous, Deep Vein Thrombosis
Adverse event resulted in: death
Drug(s) suspected as cause:
Adriamycin PFS
Dosage: 15 milligram/sq. meter
Adriamycin PFS
Dosage: 9 milligram/sq. meter
Indication: Multiple Myeloma
Cyclophosphamide
Dosage: 1000 milligram/sq. meter
Indication: Multiple Myeloma
Dexamethasone
Dosage: 40 milligram
Administration route: Oral
Dexamethasone
Dosage: 40 milligram
Administration route: Oral
Indication: Multiple Myeloma
Melphalan Hydrochloride
Dosage: 200 milligram/sq. meter
Thalomid
Dosage: induction therapy, 200 mg escalated to 400 mg, qd, with vte prophylaxis
Administration route: Oral
Indication: Multiple Myeloma
Thalomid
Dosage: maintenance therapy, 50 mg qd, without vte prophylaxis
Administration route: Oral
Other drugs received by patient: Neupogen; Mycophenolate Mophetil; Cyclosporine; Nadroparine
Possible Cyclophosphamide side effects in
Reported by a physician from France on 2012-07-09
Patient:
Reactions: Death, Lung Infection, Myocardial Infarction
Adverse event resulted in: death, life threatening event, hospitalization
Drug(s) suspected as cause:
Cyclophosphamide
Dosage: 75 mg/m2, unk
Indication: Multiple Myeloma
Start date: 2011-11-04
End date: 2012-04-01
Dexamethasone
Dosage: 20 mg, unk
Administration route: Oral
Indication: Multiple Myeloma
Start date: 2011-11-04
End date: 2012-04-01
Velcade
Dosage: 2.4 mg, unk
Indication: Multiple Myeloma
End date: 2012-04-01
Other drugs received by patient: Codeine Phosphate and Acetaminophen; Lercanidipine; Perindopril Erbumine; Acetaminophen; Clopidogrel; Plavix; Ezetimibe; Bisoprolol Fumarate
Possible Cyclophosphamide side effects in
Reported by a physician from Israel on 2012-07-05
Patient:
Reactions: Death
Adverse event resulted in: death
Drug(s) suspected as cause:
Adriamycin PFS
Indication: Multiple Myeloma
Cisplatin
Indication: Multiple Myeloma
Cyclophosphamide
Indication: Multiple Myeloma
Dexamethasone Sodium Phosphate
Indication: Multiple Myeloma
Etoposide
Indication: Multiple Myeloma
Thalidomide
Indication: Multiple Myeloma
Velcade
Indication: Multiple Myeloma
Possible Cyclophosphamide side effects in
Reported by a health professional (non-physician/pharmacist) from United States on 2012-07-02
Patient:
Reactions: Death
Adverse event resulted in: death
Drug(s) suspected as cause:
Cyclophosphamide
Indication: Acute Lymphocytic Leukaemia
Cytarabine
Indication: Acute Lymphocytic Leukaemia
Elspar
Indication: Acute Leukaemia
Idarubicin HCL
Indication: Acute Lymphocytic Leukaemia
Mercaptopurine
Indication: Acute Lymphocytic Leukaemia
Prednisone TAB
Indication: Acute Lymphocytic Leukaemia
Vincristine
Indication: Acute Lymphocytic Leukaemia
Other drugs received by patient: Dexamethasone
Possible Cyclophosphamide side effects in
Reported by a health professional (non-physician/pharmacist) from United States on 2012-07-02
Patient:
Reactions: Death
Adverse event resulted in: death
Drug(s) suspected as cause:
Cyclophosphamide
Indication: Acute Lymphocytic Leukaemia
Cytarabine
Indication: Acute Lymphocytic Leukaemia
Dexamethasone
Indication: Acute Lymphocytic Leukaemia
Elspar
Indication: Acute Lymphocytic Leukaemia
Idarubicin HCL
Indication: Acute Lymphocytic Leukaemia
Mercaptopurine
Indication: Acute Lymphocytic Leukaemia
Prednisone TAB
Indication: Acute Lymphocytic Leukaemia
Vincristine
Indication: Acute Lymphocytic Leukaemia
Page 1 Next >>
|
